All articles by Aninda Chakraborty

Aninda Chakraborty

ArchiMed acquires neurodiagnostic devices provider Natus Medical

Natus shareholders received $33.50 in cash for each share of company common stock.

Anumana partners with Novartis for AI-driven heart disease detection

The companies will deploy multiple AI-powered software solutions to identify hidden cardiovascular conditions.

Labcorp introduces blood test to detect neurodegenerative disease

The test will help diagnose diseases, such as multiple sclerosis, Alzheimer’s and Parkinson’s, as well as brain injuries.

Medtronic enters partnership with CathWorks with $585m buyout option

Medtronic will immediately begin co-promotion of CathWorks’ FFRangio System in the US, Europe and Japan.

Eko secures FDA clearance for heart disease detection software

Use of the EMAS algorithm will enable healthcare professionals to identify valvular heart disease in patients.

MMI introduces new simulator for microsurgeries

The new simulator is developed by medical simulation training company VirtaMed.

Nexus Medical Labs and Rhinostics obtain FDA EUA for SARS-CoV-2 Test

The molecular SARS-CoV-2 test relies on the RHINOstic Automated Nasal Swab from Rhinostics.

Medtronic’s revenue increases 5% to $31.69bn in FY22

The company’s fourth quarter worldwide revenue declined by 1% on a reported basis to $8.09bn.

NICE recommends Sleepio for insomnia patients instead of sleeping pills

The Sleepio app leverages an AI algorithm to offer customised digital cognitive behavioural therapy for insomnia (CBT-I).

Mainz and Dante Labs partner to commercialise colon cancer detection test

Mainz will leverage Dante’s various established commercial channels to introduce ColoAlert in Italy and the UAE.